Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (QNRX)

CUSIP: 74907L409

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 5 signals
Share change
+841,336
SEC-reported price per share
$14.43
Number of holders
18
Value change
+$12,140,475
Number of buys
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
70,007,000

Security key

74907L409

Report period

Q4 2025

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of QNRX - Quoin Pharmaceuticals, Ltd. - Ordinary Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Woodline Partners LP
Disclosed value leader
Woodline Partners LP
Comparable rows
9/10
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 9.5% 1 rows are not safely comparable across share classes. 13D/G row: Woodline Partners LP Showing 1-6 of 10 holder rows.

Quick read

Woodline Partners LP leads the comparable SEC ownership view at 9.5%.

9 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Woodline Partners LP's linked filing trail.
Comparable ownership Top 5
Woodline Partners LP 9.5%
Resolute Capital Asset Partners LLC 8.5%
ARMISTICE CAPITAL, LLC 5%
Denise P. Carter 4.9%
Michael Myers 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 10 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Woodline Partners LP
13D/G
9.5%
$38,298,838
2,785,370 shares
$0 31 Dec 2025
Resolute Capital Asset Partners LLC
13D/G
8.5%
$671,000
50,000 shares
$0 10 Oct 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
$7,049,313
1,081,183 shares
$0 31 Mar 2025
Denise P. Carter
13D/G
Denise Carter
4.9%
$244,202
939,238 shares
+$82,374 27 Jan 2025
Michael Myers
13D/G
4.9%
$244,200
939,230 shares
+$82,331 27 Jan 2025
RHUMBLINE ADVISERS
13F
Company
13F
0%
$8,696
1,210 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
842,827
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
4
Q4 2025 holders
18
Holder diff
14
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .